Deja Vu!
RAC 2022 AGM Strategy
RAC 2023 AGM Strategy
Just brush this failed deliverable under the rug with the rest of them? I had hoped they might at least acknowledge the missteps taken to date, how they've learned from them and how they plan on avoiding them in the future.
And now it's all up to shareholders if we want to fund AML+Decitabine in a low dose setting, you know, like the trial we coughed up for in 2021.
Ann: Updated Strategy and Investor Presentation, page-154
-
- There are more pages in this discussion • 355 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.040(2.86%) |
Mkt cap ! $245.3M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.49 | $1.41 | $101.7K | 69.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9216 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 7767 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |